Author bought LifeMD shares citing debt-free cash-flow positive status, revenue traction, and Wegovy oral pill supply approval.
LFMD — LONG The author argues LifeMD is undervalued because it generated $260 million in trailing revenue, paid off all debt, is cash-flow positive, and trades at a $185 million market cap near a 52-week low. The company received approval to supply Novo Nordisk's oral Wegovy pill, which the author treats as a concrete positive catalyst. The author bought 10,000 shares based on this view.
They made $260m in the last 12 months . They paid off all debt recently. The market cap is like $185m.
This Reddit post, published January 05, 2026, features u/Get_rch_or_try_dyin discussing LFMD. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Get_rch_or_try_dyin · Tickers: LFMD